Shinsei Bank appeared to be the Corporate Investor, which was created in 1952. The main department of described Corporate Investor is located in the Tokyo. The fund was located in Asia if to be more exact in Japan.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Shinsei Bank, startups are often financed by JAFCO Japan, Infoteria Corporation, OKWave. The meaningful sponsors for the fund in investment in the same round are Nippon Venture Capital, SMBC Venture Capital, Mitsubishi UFJ Capital. In the next rounds fund is usually obtained by B Dash Ventures, Yamaguchi Capital, World Innovation Lab (WiL).
Considering the real fund results, this Corporate Investor is 5 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2016. The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Shinsei Bank performs on 4 percentage points less the average number of lead investments. The high activity for fund was in 2019. The fund is constantly included in less than 2 investment rounds annually.
The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. We can highlight the next thriving fund investment areas, such as Biotechnology, Information Technology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Japan. Among the most popular portfolio startups of the fund, we may highlight gumi, Symic Biomedical, Arcterus. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
CAMELOVE | 21 Aug 2019 | Chiyoda | |||
OLTA | $22M | 26 Jun 2019 | Chiyoda, Japan | ||
Symic Biomedical | $11M | 25 Apr 2019 | California, United States | ||
Upsider | 01 Jan 2019 | Chiyoda, Japan | |||
Arcterus | $910K | 02 Dec 2018 | Chiyoda, Japan | ||
Crowd Realty | $2M | 25 Jan 2018 | Chiyoda, Japan | ||
Seven Dreamers Laboratories | $13M | 08 Jun 2015 | Japan, Chiyoda | ||
Uzabase | $4M | 29 Aug 2014 | Chiyoda, Japan | ||
$6M | 02 Jul 2013 | Japan, Osaka Prefecture |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
CAMELOVE | 21 Aug 2019 | Chiyoda | |||
OLTA | $22M | 26 Jun 2019 | Chiyoda, Japan | ||
Symic Biomedical | $11M | 25 Apr 2019 | California, United States | ||
Upsider | 01 Jan 2019 | Chiyoda, Japan | |||
Arcterus | $910K | 02 Dec 2018 | Chiyoda, Japan | ||
Crowd Realty | $2M | 25 Jan 2018 | Chiyoda, Japan | ||
Seven Dreamers Laboratories | $13M | 08 Jun 2015 | Japan, Chiyoda | ||
Uzabase | $4M | 29 Aug 2014 | Chiyoda, Japan | ||
$6M | 02 Jul 2013 | Japan, Osaka Prefecture |